tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Eli Lilly’s TRANSCEND-T2D-1 Trial Completion: What Retatrutide Could Mean for LLY Investors
PremiumCompany AnnouncementsEli Lilly’s TRANSCEND-T2D-1 Trial Completion: What Retatrutide Could Mean for LLY Investors
3d ago
Your Boss May Soon Cover the Cost of Obesity Drugs. Here’s Eli Lilly’s (LLY) Plan
Premium
Market News
Your Boss May Soon Cover the Cost of Obesity Drugs. Here’s Eli Lilly’s (LLY) Plan
3d ago
Eli Lilly launches program to expand employer coverage of obesity drugs
Premium
The Fly
Eli Lilly launches program to expand employer coverage of obesity drugs
3d ago
Lilly Advances Remternetug Testing in China, Extending Its Alzheimer’s Pipeline Reach
PremiumCompany AnnouncementsLilly Advances Remternetug Testing in China, Extending Its Alzheimer’s Pipeline Reach
5d ago
Eli Lilly Advances New Oral Diabetes Drug In China: What Investors Should Watch
Premium
Company Announcements
Eli Lilly Advances New Oral Diabetes Drug In China: What Investors Should Watch
5d ago
Can Hims & Hers Overcome FDA’s GLP-1 Crackdown?
Premium
Market News
Can Hims & Hers Overcome FDA’s GLP-1 Crackdown?
5d ago
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
PremiumMarket NewsKURE vs. VHT: Comparing China and U.S. Healthcare ETFs
6d ago
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
Premium
Market News
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
8d ago
The Week That Was, The Week Ahead: Macro and Markets, Mar. 1
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Mar. 1
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100